Ischemic and Bleeding Events of Ticagrelor Monotherapy in Korean Patients With and Without Diabetes Mellitus: Insights From the TICO Trial

Background: Ticagrelor monotherapy after 3 months dual antiplatelet therapy (DAPT) with aspirin and ticagrelor can reduce bleeding without increasing ischemic events after percutaneous coronary intervention (PCI). However, the impact of this approach among the patient with diabetes remains unknown....

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Front Pharmacol
Main Authors: Yun, Kyeong Ho, Cho, Jae Young, Lee, Seung Yul, Rhee, Sang Jae, Kim, Byeong Keuk, Hong, Myeong Ki, Jang, Yangsoo, Oh, Seok Kyu
Formato: Artigo
Idioma:Inglês
Publicado em: Frontiers Media S.A. 2021
Assuntos:
Pharmacology
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7845141/
https://ncbi.nlm.nih.gov/pubmed/33519487
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fphar.2020.620906
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados